American Society of Hematology

SHERPA: Blue

People

  1. Sadelain
    Sadelain
  2. Park
    Park
  3. Wang
    Wang
  4. Curran
    Curran
  5. Bernal
    Bernal
  6. O'Reilly
    O'Reilly
  7. Giralt
    Giralt
  8. Palomba
    Palomba
  9. Kernan
    Kernan
  10. Stefanski
    Stefanski

Groups

  1. Department of Medicine (47)
  2. Hematologic Malignancies, Division of (47)
  3. Center for Hematologic Malignancies (46)
  4. GSK Faculty (46)
  5. Hematologic Malignancies Research (46)
  6. Sloan Kettering Institute Faculty (42)
  7. Molecular Pharmacology and Chemistry Program Faculty (41)
  8. Adult Leukemia (31)
  9. Pediatrics, Department of (17)
  10. Stem Cell Transplantation and Cellular Therapy Service (16)
Search Within
  1. "Meeting abstract"
  2. "Isabelle Riviere"
Formats
  1. Meeting Abstract (47)
Groups
  1. Department of Medicine (47)
  2. Hematologic Malignancies, Division of (47)
  3. Center for Hematologic Malignancies (46)
  4. GSK Faculty (46)
  5. Hematologic Malignancies Research (46)
  6. Sloan Kettering Institute Faculty (42)

More Groups

People
  1. Isabelle Riviere (47)
  2. Michel Sadelain (41)
  3. Renier Brentjens (29)
  4. Jae Park (25)
  5. Xiuyan Wang (24)
  6. Kevin Curran (12)

More People

Years
  1. 2023 (2)
  2. 2022 (3)
  3. 2021 (3)
  4. 2020 (2)
  5. 2019 (2)
  6. 2018 (5)

More Years

Publications
  1. Blood (47)

Results (47)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Long term follow-up after treatment with allogeneic off-the-shelf CAR T cell therapy for relapsed or refractory B-cell malignancies
    Meeting Abstract

    Shahid, S.; Flynn, G. C.; Mauguen, A.; Bieler, J.; Prockop, S. E.; Scaradavou, A.; Boelens, J. J.; Sauter, C. S.; Perales, M. A.; Giralt, S. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • A phase II trial of prophylactic anakinra to prevent neurotoxicity in patients receiving anti-CD19 CAR T-cell therapy for relapsed or refractory lymphoma: Final results from cohort 2
    Meeting Abstract

    Nath, K.; Devlin, S. M.; Sauter, C. S.; Palomba, M. L.; Shah, G. L.; Dahi, P. B.; Lin, R. J.; Scordo, M.; Perales, M. A.; Leslie, L. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • The development of allogeneic tips-derived TCR(-)CAR(+) CD8αβ T cells
    Meeting Abstract

    van der Stegen, S. J. C.; Petrovic, R. M.; Lindenbergh, P. L.; Diop, M. P.; Alexeeva, V.; Xie, H.; Clarke, R.; Valamehr, B.; Rivière, I.; Sadelain, M.
    Blood (2022)

    Fulltext@MSK | Save
  • A phase I study of CD19-targeted 19(T2)28z1XX CAR T cells in adult patients with relapsed or refractory diffuse large B-cell lymphoma
    Meeting Abstract

    Park, J. H.; Palomba, M. L.; Rivière, I.; Sikder, D. S.; Senechal, B.; Wang, X.; Bermudez, V. P.; Cathcart, E. R.; Liotta, K.; Joseph, J.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Target densities in malignant and normal cells determine CAR T cell efficacy and off-target hematotoxicity
    Meeting Abstract

    Haubner, S.; Mansilla-Soto, J.; Nataraj, S.; Kogel, F.; Chang, Q.; De Stanchina, E.; Fraser, K.; Park, J. H.; Wang, X.; Rivière, I.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Clinical manufacture of FT819: Use of a clonal multiplexed-engineered master induced pluripotent stem cell line to mass produce off-the-shelf CAR T-cell therapy
    Meeting Abstract

    Yuan, X.; Clarke, R.; Lai, Y. S.; Chang, C. W.; Yang, B. H.; Hsia, G.; Abujarour, R.; Lee, T.; van der Stegen, S.; Shaked, H.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • The intestinal microbiota correlates with response and toxicity after CAR T cell therapy in patients with B-cell malignancies
    Meeting Abstract

    Smith, M.; Dai, A.; Ghilardi, G.; Amelsberg, K.; Devlin, S. M.; Pajarillo, R.; Slingerland, J. B.; Beghi, S.; Herrera, P. S.; Giardina, P. A.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Phase I first-in-class trial of MCARH109, a G protein coupled receptor class C group 5 member D (GPRC5D) targeted CAR T cell therapy in patients with relapsed or refractory multiple myeloma
    Meeting Abstract

    Mailankody, S.; Diamonte, C.; Fitzgerald, L.; Kane, P.; Wang, X.; Sikder, D. S.; Senechal, B.; Bermudez, V. P.; Frias, D.; Morgan, J.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • NOTCH and CAR signaling control T cell lineage commitment from pluripotent stem cells
    Meeting Abstract

    Van der Stegen, S.; Lindenbergh, P.; Petrovic, R.; Whitlock, B.; Clarke, R.; Valamehr, B.; Riviere, I.; Sadelain, M.
    Blood (2020)

    Fulltext@MSK | Save
  • A phase I study of CD19-targeted 19(T2)28z1xx CAR T cells in adult patients with relapsed or refractory B-cell malignancies
    Meeting Abstract

    Park, J. H.; Riviere, I.; Sikder, D. S.; Bermudez, V. P.; Senechal, B.; Wang, X.; Auchincloss, T. H.; Diamonte, C.; Halton, E.; Palomba, M. L.; more...
    Blood (2020)

    Fulltext@MSK | Save